Travere Therapeutics (TVTX) Preferred Shares (2012)
Travere Therapeutics (TVTX) reported Preferred Shares of $1.0 for Q4 2012, little changed quarter-over-quarter from $1.0 in Q1 2012.
Travere Therapeutics (TVTX) Preferred Shares (2012) Analysis & Trends
Travere Therapeutics has reported Preferred Shares for 1 years, with the latest figure at $1.0 in Q4 2012.
- For the quarter ending Q4 2012, Preferred Shares changed N/A year-over-year to $1.0; the trailing twelve-month figure through Nov 2012 stood at $1.0 (changed N/A YoY), and the FY2012 full-year result was $1.0, changed N/A from the prior year.
- Preferred Shares for Q4 2012 stood at $1.0, roughly flat from $1.0 in the prior quarter.
- The five-year high for Preferred Shares was $1.0 in Q1 2012, with the low at $1.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Travere Therapeutics | 5.07 Bn | 4.99 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2012 | 1.00 |
| Feb 29, 2012 | 1.00 |